1. Home
  2. BAFN vs NBY Comparison

BAFN vs NBY Comparison

Compare BAFN & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BayFirst Financial Corp.

BAFN

BayFirst Financial Corp.

N/A

Current Price

$5.87

Market Cap

30.9M

Sector

Finance

ML Signal

N/A

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$1.23

Market Cap

31.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAFN
NBY
Founded
1999
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
30.9M
31.6M
IPO Year
2021
2007

Fundamental Metrics

Financial Performance
Metric
BAFN
NBY
Price
$5.87
$1.23
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
16.1K
869.6K
Earning Date
04-23-2026
03-31-2026
Dividend Yield
1.39%
N/A
EPS Growth
133.93
35.42
EPS
N/A
0.76
Revenue
N/A
$370,000.00
Revenue This Year
N/A
$23.91
Revenue Next Year
N/A
$32.05
P/E Ratio
N/A
$1.67
Revenue Growth
N/A
N/A
52 Week Low
$4.80
$0.43
52 Week High
$19.00
$19.95

Technical Indicators

Market Signals
Indicator
BAFN
NBY
Relative Strength Index (RSI) 43.65 42.69
Support Level N/A $0.99
Resistance Level $8.37 $1.36
Average True Range (ATR) 0.55 0.21
MACD -0.02 0.12
Stochastic Oscillator 47.82 14.19

Price Performance

Historical Comparison
BAFN
NBY

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: